IGC Pharma IGC
NYSE IGC
$0.25 +0.00 (+0.20%)
As of: Oct 21, 2026 · 3:54 PM EDT

IGC Pharma (IGC) Short term Debt (2012 - 2026)

Updated

IGC Pharma (IGC) posted Short term Debt of $726,000 for Q4 2026, up 303.3% from the prior quarter.

Analysis

IGC Pharma (IGC) Short term Debt (2012 - 2026) Analysis & Trends

Since Q4 2012, IGC Pharma has reported Short term Debt for 9 quarters.

  • The Q4 2026 figure stands as the highest quarterly Short term Debt in data going back to Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 IGC Pharma 24.10 Mn 21.34 Mn 55,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 726,000.00
Dec 31, 2025 180,000.00
Jun 30, 2016 133,333.00
Mar 31, 2016 189,680.00
Sep 30, 2015 166,236.00
Jun 30, 2015 111,919.00
Mar 31, 2015 73,707.00
Mar 31, 2014 424,845.00
Mar 31, 2012 210,010.00
API Access

IGC Pharma Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IGC&period=max&api_key=YOUR_API_KEY